Moderna set off a frenzy with its vaccine trial. Some are calling for an investigation

Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary results from its coronavirus vaccine trial. As the hype grew, the young biotech company and its leading investor wasted no time capitalizing on the briefly surging stock price.

Click Here to read the entire article...